Next Generation Sequencing (NGS) Market to be worth $27.5 Billion by 2030 Meticulous Research® Unveils Comprehensive Market Insight in Latest Report: "Next Generation Sequencing (NGS) Market Poised for Remarkable Growth by 2030" Meticulous Research®, a globally renowned market research company, is pleased to announce the release of its latest research report titled, "Next Generation Sequencing (NGS) Market by Offering (Kits [Library Prep, QC, DNA Extraction], System) Type (Genome, Exome, Targeted) Application (Reproductive, Oncology, Infectious) Technology (SBS, Nanopore, Nanoball, SMRT Seq) – Global Forecast to 2030." Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5040 To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/next-generation-sequencing-market-5040 Key Players Driving NGS Innovation: Leading the charge in the global NGS market are prominent players including Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), PerkinElmer, Inc. (U.S.), Qiagen N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Pacific Biosciences of California, Inc. (U.S.), Danaher Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Oxford Nanopore Technologies Plc. (U.K.), 10X Genomics, Inc. (U.S.), and Beijing Genomics Institute (BGI) (China). Future Outlook of the NGS Market: Have Any Query ? Speak To Our Analyst: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5040 Meticulous Research® continues to be at the forefront of delivering in-depth market intelligence, empowering businesses to make informed decisions in an ever-evolving global landscape. For a detailed analysis of the NGS market and its potential impact on your business, access the full report on our website or contact our research experts. Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5040 Related Research: 1. Latin America Next Generation Sequencing (NGS)Market by Type (Consumables, NGS Platform), Sequencing Type (Whole Genome, Targeted), Technology (Sequencing by Synthesis, Sequencing by Ligation), Application (Clinical, Research), End User - Forecast to 2027 https://www.meticulousresearch.com/product/latin-america-next-generation-sequencing-market-5106 2. Asia-Pacific Next Generation Sequencing (NGS) Market by Offering (Kits [Library Prep, QC, DNA Extraction], System), Type (Genome, Exome, Targeted), Application (Reproductive, Oncology), Technology (SBS, Nanopore, Nanoball, SMRT Seq) – Forecast to 2030 https://www.meticulousresearch.com/product/asia-pacific-next-generation-sequencing-market-5722 3. Next Generation Sequencing (NGS) Informatics Market by Offering (Data Analysis, Interpretation & Reporting, Storage & Computing, LIMS) Application (Diagnostic, Drug Discovery, Precision Medicine, Biomarker Discovery) End User - Global Forecast to 2030 https://www.meticulousresearch.com/product/ngs-informatics-market-3483 4. Europe NGS Market by Offering (Kits [Library Prep, QC, DNA Extraction], System), Type (Genome, Exome, Targeted), Application (Reproductive, Oncology, Infectious, CVD, Drug Discovery), Technology (SBS, Nanopore, Nanoball, SMRT Seq, DNB) – Forecast to 2030 https://www.meticulousresearch.com/product/europe-ngs-market-5744 5. Middle East & Africa NGS Market by Offering (Kits [Library Prep, QC, DNA Extraction], System) Type (Genome, Exome, Targeted), Application (Reproductive, Oncology, Infectious, Drug Discovery), Technology (SBS, Nanopore, Nanoball, SMRT Seq) – Forecast to 2031 https://www.meticulousresearch.com/product/middle-east-and-africa-ngs-market-5786

Charting the Growth and Innovations in the 3D Bioprinting Market The 3D Bioprinting Market is projected to reach $5.21 billion by 2030, at a CAGR of 17.1% from 2023 to 2030. 3D Bioprinting is an approach of additive manufacturing technique that employs biomaterials and cells compared to traditional polymers, and metals to generate functional 3D tissues. The 3D Bioprinting incorporates pre-bioprinting, bioprinting, and post-bioprinting. This technology is employed in various research areas, such as regenerative medicines, cancer research, tissue engineering, and many others. Several 3D bioprinting techniques have been developed utilizing inkjet printheads, laser-induced, acoustic wave, applied pressure, and solenoid valve-based methods to deposit cells onto substrates. The preference for 3D bioprinting is increasing compared to conventionally used techniques mainly because of the ability of 3D bioprinting to digitally define the tissue construct of interest and reproduce the physical 3D structure using automated techniques with resolutions not possible through any conventional techniques. 𝐂𝐥𝐢𝐜𝐤 𝐇𝐞𝐫𝐞 𝐅𝐨𝐫 𝐏𝐃𝐅 https://www.meticulousresearch.com/download-sample-report/cp_id=5746 Asia-Pacific: Fastest-growing Regional Market The growth of this regional market is attributed to the increasing incidence of cancer, the presence of key 3D bioprinting companies in countries like China, India, Singapore, and Japan, advancements in technology related to 3D bioprinting such as improved vascularization of printed tissues, high resolution of bioprinters, and government investments in research and development activities. Report Summary: Particular Details Page No 200 Format PDF Forecast Period 2023-2030 Base Year 2022 CAGR 17.1% Market Size (Value) $5.21 billion Segments Covered Product, Technology, Application, and End User Click here to: Get Free Sample Pages of this Report Scope of the Report: 3D Bioprinting Market Size & Trend Analysis, by Product • Bioprinters • Bioinks • Materials o Hydrogels o Living Cells o Extracellular Matrices o Biomaterials o Other Materials • Software • Accessories and Consumables (Note: Other materials include synthetic polymers, composites, and nanocellulose) 3D Bioprinting Market Size & Trend Analysis, by Technology • Inkjet-based • Extrusion-based • Stereolithography (SLA) • Laser-based • Fused-deposition modeling (FDM) • Selective laser sintering (SLS) • Other Technologies (Note: Other technologies include Digital Light Processing (DLP), Injection pore filling (IPF), and Injection volume filling (IVF)) 3D Bioprinting Market Size & Trend Analysis, by Application • Cancer Research • Regenerative Medicines • Drug Discovery and Testing • Tissue Engineering • Biomaterials and cells research • Other Applications (Note: Other applications include organ transplantation, tissue, and disease modeling) 3D Bioprinting Market Size & Trend Analysis, by End User • Pharmaceutical and Biotechnology Companies • Academic and Research Institutes • Contract Research Organizations (CROs) 3D Bioprinting Market Size & Trend Analysis, by Geography • North America o U.S. o Canada • Europe o Germany o France o Italy o U.K. o Spain o Rest of Europe • Asia-Pacific o China o Japan o India o Rest of Asia-Pacific • Latin America o Brazil o Mexico o Rest of Latin America o Middle East & Africa 𝐇𝐚𝐯𝐞 𝐚𝐧𝐲 𝐪𝐮𝐞𝐫𝐲 𝐀𝐒𝐊 𝐄𝐗𝐏𝐄𝐑𝐓 : https://www.meticulousresearch.com/speak-to-analyst/cp_id=5746 Key Players The report offers a competitive landscape based on an extensive assessment of the product offerings and geographic presence of leading market players and the key growth strategies adopted by them in the last three to four years. The key players profiled in the 3D bioprinting market report are Organovo Holdings Inc. (U.S.), BICO Group AB (Sweden), Aspect Biosystems Ltd. (Canada), Cyfuse Biomedical K.K. (Japan), Advanced Solutions Life Sciences, LLC (U.S.), CollPlant Biotechnologies Ltd. (Israel), regenHU Ltd. (Switzerland), Poietis (France), REGEMAT 3D, SL (Spain), 3DBio Therapeutics (U.S.), and Foldink Life Science Technologies (Armenia). 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐍𝐨𝐰 https://www.meticulousresearch.com/download-sample-report/cp_id=5746

Leading the Genomic Revolution: A Comprehensive Look at the Top Companies in the North America NGS Automation Market ‘North America NGS Automation Market by Product {Workstations, Consumables}, Sequencing Type {Whole Genome, Exome, Targeted Genome}, Application {Drug Discovery, Diagnostics, Oncology}, End User {Hospitals, Pharmaceutical, Diagnostic Labs} - Forecast to 2030.’ https://www.meticulousresearch.com/product/north-america-ngs-automation-market-5736 Here are some companies that were notable in the NGS industry: 1. Agilent Technologies, Inc. (U.S.), 2. Danaher Corporation (U.S.), 3. Eppendorf AG (Germany), 4. Hamilton Company (U.S.), 5. PerkinElmer, Inc. (U.S.), 6. Tecan Group Ltd. (Switzerland), 7. BRAND GMBH + CO KG (Germany), 8. Hudson Robotics (U.S.), 9. SPT Labtech (U.K.), 10. Thermo Fisher Scientific Inc. (U.S.), 11. F. Hoffmann-La Roche Ltd. (Switzerland). According to this latest publication from Meticulous Research®, the North America NGS automation market is expected to register a CAGR of 14% from 2023 to reach $776.1 million by 2030. The growth of the North America NGS automation market is attributed to the increasing prevalence of cancer cases, rising demand for NGS automation in laboratories, growing demand for optimized & streamlined workflows, and increasing pharmaceutical R&D investments & healthcare expenditures. Furthermore, the rising application of NGS technology and collaborations between vendors to develop library preparation protocols are expected to offer immense growth opportunities for market expansion 𝐆𝐞𝐭 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐒𝐭𝐮𝐝𝐲, 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐏𝐃𝐅- North America NGS Automation Market - Opportunity Analysis and Industry Forecast (2023-2030) |Download Sample Report (https://www.meticulousresearch.com/download-sample-report/cp_id=5736) Scope of the Report: North America NGS Automation Market Assessment, by Product • Workstations/Robotic Platforms • Reagents & Consumables North America NGS Automation Market Assessment, by Sequencing Type • Whole Genome Sequencing • Whole Exome Sequencing • Targeted Genome Sequencing • Other Sequencing Types (Note: The sequencing type comprises degradome sequencing, chromatin immunoprecipitation (ChIP) sequencing, and methylation sequencing) North America NGS Automation Market Assessment, by Application • Drug Discovery • Clinical Diagnostics o Reproductive Health Diagnostics o Oncology Diagnostics o Infectious Disease Diagnostics o Other Clinical Diagnostics Applications • Other Applications North America NGS Automation Market Assessment, by End User • Pharmaceutical & Biotechnology Companies • Hospitals & Diagnostic Laboratories • Academics & Research Institutes • Other End Users (Note: The other end users comprise forensic laboratories & security agencies, the food industry, and the agriculture industry) North America NGS Automation Market Assessment, by Country • U.S. • Canada Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5736Key questions answered in the report: • What are the high-growth market segments regarding the product, sequencing type, application, end user, and country? • What was the historical market for North America NGS automation? • What are the market forecasts and estimates for 2023–2030? • What are the major drivers, restraints, challenges, and opportunities in the North America NGS automation market? • Who are the major players in the North America NGS automation market? Need more information? Meticulous Research®’s new report covers each of these companies in much more detail, providing analysis on the following: • Recent financial performance • Key products • Significant company strategies • Partnerships and acquisitions The Comprehensive report provides global market size estimates, market share analysis, revenue numbers, and coverage of key issues and trends. North America NGS Automation Market - Opportunity Analysis and Industry Forecast (2023-2030) |Speak To Analyst (https://www.meticulousresearch.com/speak-to-analyst/cp_id=5736) Contact Us: Meticulous Research® Email- [email protected] (mailto:[email protected]) Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- Meticulous Research® | LinkedIn (https://www.linkedin.com/company/meticulous-research)

Harnessing the Potential of Negative Pressure Wound Therapy (NPWT): Market Outlook and Future Prospects https://www.marketsandmarkets.com/Market-Reports/negative-pressure-wound-therapy-market-215139824.html The global NPWT devices market is projected to reach USD 3.2 billion by 2025 from USD 2.4 billion in 2020, at a CAGR of 6.1%. The rising prevalence of diabetes, increasing spending on chronic and surgical wounds, government initiatives to prevent SSIs, and the high rate of cesarean sections in elderly mothers are the major factors driving the growth of the NPWT devices market. Also, emerging markets and the increasing sale of disposables and single-use consumables, are expected to offer growth opportunities for players operating in the NPWT devices market. The prominent players in the NPWT devices market are Acelity L.P. Inc. (US), Smith & Nephew (UK), Mölnlycke Healthcare AB (Sweden), ConvaTec Group Plc (UK), Cardinal Health (US), Paul Hartmann AG (Germany), DeRoyal (US), Lohmann & Rauscher International GmbH & Co KG. (Germany), Medela LLC (Switzerland), Genadyne Biotechnologies, Inc. (US), Triage Meditech Pvt. Ltd. (Delhi), Talley Group (UK), Alleva Medical Ltd. (China), Cork Medical (US), 4L Health Co. Ltd. (China), Carilex Medical GmbH (Germany), ChongQing Sunshine Medical Industry & Trading Co (China), Wuhan VSD Medical Science & Technology Co. Ltd. (China), Pensar Medical (US), and Haromed Bvba (Belgium).